Tenaya Therapeutics Inc (NASDAQ: TNYA) on Friday, plunged -6.06% from the previous trading day, before settling in for the closing price of $0.44. Within the past 52 weeks, TNYA’s price has moved between $0.39 and $4.78.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 40.20%. With a float of $134.16 million, this company’s outstanding shares have now reached $162.66 million.
The firm has a total of 97 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tenaya Therapeutics Inc (TNYA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tenaya Therapeutics Inc is 17.52%, while institutional ownership is 26.26%. The most recent insider transaction that took place on Mar 10 ’25, was worth 1,336. In this transaction SVP, Finance of this company sold 2,482 shares at a rate of $0.54, taking the stock ownership to the 99,690 shares. Before that another transaction happened on Mar 10 ’25, when Company’s Chief Medical Officer sold 7,398 for $0.54, making the entire transaction worth $3,983. This insider now owns 174,793 shares in total.
Tenaya Therapeutics Inc (TNYA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 40.20% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Tenaya Therapeutics Inc (TNYA) is currently performing well based on its current performance indicators. A quick ratio of 6.68 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.16, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Analysing the last 5-days average volume posted by the [Tenaya Therapeutics Inc, TNYA], we can find that recorded value of 2.74 million was lower than the volume posted last year of 3.0 million. As of the previous 9 days, the stock’s Stochastic %D was 17.04%. Additionally, its Average True Range was 0.05.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 0.85%, which indicates a significant decrease from 15.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.18% in the past 14 days, which was lower than the 190.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5494, while its 200-day Moving Average is $1.7165. Now, the first resistance to watch is $0.4452. This is followed by the second major resistance level at $0.4766. The third major resistance level sits at $0.5031. If the price goes on to break the first support level at $0.3873, it is likely to go to the next support level at $0.3608. Now, if the price goes above the second support level, the third support stands at $0.3294.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
Market capitalization of the company is 67.33 million based on 87,583K outstanding shares. Right now, sales total 0 K and income totals -111,130 K. The company made 0 K in profit during its latest quarter, and -23,840 K in sales during its previous quarter.
